TrialThe Journal of infectious diseases2025

Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial.

Jintanat Ananworanich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.